From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Annual Review of Genetics

• Publication date

  2015-12-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1146/annurev-genet-112414-054926PMID 26407033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resource Engineering Complex Synthetic Transcriptional Programs with CRISPR RNA Scaffolds

  2015cited by this paper
• An AAVS1-targeted minigene platform for correction of iPSCs from all five types of chronic granulomatous disease.

  2015cited by this paper
• Resetting Transcription Factor Control Circuitry toward Ground-State Pluripotency in Human

  2014cited by this paper
• Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases

  2014cited by this paper
• Homology-directed repair of DNA nicks via pathways distinct from canonical double-strand break repair

  2014cited by this paper
• CRISPR-Cas systems for editing, regulating and targeting genomes

  2014cited by this paper
• A guide to genome engineering with programmable nucleases

  2014cited by this paper
• Targeted gene therapy and cell reprogramming in Fanconi anemia

  2014cited by this paper
• Generation of the SCN1A epilepsy mutation in hiPS cells using the TALEN technique

  2014cited by this paper
• Targeted genome editing tools for disease modeling and gene therapy.

  2014cited by this paper
• Systematic Identification of Culture Conditions for Induction and Maintenance of Naive Human Pluripotency

  2014cited by this paper
• Delivery of Full-Length Factor VIII Using a piggyBac Transposon Vector to Correct a Mouse Model of Hemophilia A

  2014cited by this paper
• BBS mutations modify phenotypic expression of CEP290-related ciliopathies.

  2014cited by this paper
• Genetic correction using engineered nucleases for gene therapy applications

  2014cited by this paper
• Precise Gene Modification Mediated by TALEN and Single-Stranded Oligodeoxynucleotides in Human Cells

  2014cited by this paper
• Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

  2014cited by this paper
• CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences

  2014cited by this paper
• Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac

  2014cited by this paper
• Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs.

  2014cited by this paper
• Microhomology-based choice of Cas9 nuclease target sites

  2014cited by this paper
• Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection

  2014cited by this paper
• GUIDE-Seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases

  2014cited by this paper
• Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1.

  2014cited by this paper
• Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing.

  2014cited by this paper
• Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones.

  2014cited by this paper
• Targeted inversion and reversion of the blood coagulation factor 8 gene in human iPS cells using TALENs

  2014cited by this paper
• Targeted and genome-wide sequencing reveal single nucleotide variations impacting specificity of Cas9 in human stem cells

  2014cited by this paper
• CRISPR/Cas9 for genome editing: progress, implications and challenges.

  2014cited by this paper
• An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells.

  2014cited by this paper
• Isolation of rare recombinants without using selectable markers for one-step seamless BAC mutagenesis

  2014cited by this paper
• m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells.

  2014cited by this paper
• Characterization of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Sheets Aiming for Clinical Application

  2014cited by this paper
• Development and applications of CRISPR-Cas9 for genome engineering.

  2014cited by this paper
• "Viable Offspring Derived from Fetal and Adult Mammalian Cells" (1997), by Ian Wilmut et al.

  2014cited by this paper
• A CRISPR/Cas9-Based System for Reprogramming Cell Lineage Specification

  2014cited by this paper
• A protein-tagging system for signal amplification in gene expression and fluorescence imaging.

  2014cited by this paper
• Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming.

  2014cited by this paper
• Restoration of Progranulin Expression Rescues Cortical Neuron Generation in an Induced Pluripotent Stem Cell Model of Frontotemporal Dementia

  2014cited by this paper
• Systematic Identification of Culture Conditions for Induction and Maintenance of Naive Human Pluripotency

  2014cited by this paper
• Human Intestinal Tissue with Adult Stem Cell Properties Derived from Pluripotent Stem Cells

  2014cited by this paper
• iPS cells: a game changer for future medicine

  2014cited by this paper
• Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells

  2014cited by this paper
• Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9

  2014cited by this paper
• Genetic and Chemical Correction of Cholesterol Accumulation and Impaired Autophagy in Hepatic and Neural Cells Derived from Niemann-Pick Type C Patient-Specific iPS Cells

  2014cited by this paper
• Isolation of single-base genome-edited human iPS cells without antibiotic selection

  2014cited by this paper
• Derivation of novel human ground state naive pluripotent stem cells

  2013cited by this paper
• Multiplex Genome Engineering Using CRISPR/Cas Systems

  2013cited by this paper
• RNA-programmed genome editing in human cells

  2013cited by this paper
• Mammalian Base Excision Repair: the Forgotten Archangel

  2013cited by this paper
• High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

  2013cited by this paper
• Transcription Activator-like Effector Nuclease (TALEN)-mediated Gene Correction in Integration-free β-Thalassemia Induced Pluripotent Stem Cells*

  2013cited by this paper
• Efficient Clinical Scale Gene Modification via Zinc Finger Nuclease–Targeted Disruption of the HIV Co-receptor CCR5

  2013cited by this paper
• Deterministic direct reprogramming of somatic cells to pluripotency

  2013cited by this paper
• Translating Dosage Compensation to Trisomy 21

  2013cited by this paper
• ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.

  2013cited by this paper
• RNA-guided gene activation by CRISPR-Cas9-based transcription factors

  2013cited by this paper
• Generation of an ICF Syndrome Model by Efficient Genome Editing of Human Induced Pluripotent Stem Cells Using the CRISPR System

  2013cited by this paper
• Demarcation of Stable Subpopulations within the Pluripotent hESC Compartment

  2013cited by this paper
• DICE, an efficient system for iterative genomic editing in human pluripotent stem cells

  2013cited by this paper
• Efficient drug screening and gene correction for treating liver disease using patient‐specific stem cells

  2013cited by this paper
• Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

  2013cited by this paper
• CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes.

  2013cited by this paper
• CRISPR RNA-guided activation of endogenous human genes

  2013cited by this paper
• Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients.

  2013cited by this paper
• Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system

  2013cited by this paper
• One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.

  2013cited by this paper
• RNA-Guided Human Genome Engineering via Cas9

  2013cited by this paper
• Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression.

  2013cited by this paper
• One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering.

  2013cited by this paper
• DNA targeting specificity of RNA-guided Cas9 nucleases

  2013cited by this paper
• TALEN-based gene correction for epidermolysis bullosa.

  2013cited by this paper
• Efficient TALEN construction and evaluation methods for human cell and animal applications

  2013cited by this paper
• Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs.

  2013cited by this paper
• Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients

  2013cited by this paper
• New Frontier in Regenerative Medicine: Site-Specific Gene Correction in Patient-Specific Induced Pluripotent Stem Cells

  2013cited by this paper
• A Cut above the Rest: Targeted Genome Editing Technologies in Human Pluripotent Stem Cells*

  2013cited by this paper
• CRISPR-assisted editing of bacterial genomes

  2013cited by this paper
• A TALEN genome-editing system for generating human stem cell-based disease models.

  2013cited by this paper
• Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells

  2013cited by this paper
• Optimization of scarless human stem cell genome editing

  2013cited by this paper
• Genetic Correction of Tauopathy Phenotypes in Neurons Derived from Human Induced Pluripotent Stem Cells

  2013cited by this paper
• Targeted chromosomal duplications and inversions in the human genome using zinc finger nucleases.

  2012cited by this paper
• Zinc finger nucleases: looking toward translation

  2012cited by this paper
• Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors.

  2012cited by this paper
• A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

  2012cited by this paper
• SnapShot: directed differentiation of pluripotent stem cells.

  2012cited by this paper
• Embryonic stem cell trials for macular degeneration: a preliminary report.

  2012cited by this paper
• Zinc-finger nuclease-mediated correction of α-thalassemia in iPS cells.

  2012cited by this paper
• Generation of CD34+ Cells from CCR5-Disrupted Human Embryonic and Induced Pluripotent Stem Cells

  2012cited by this paper
• In brief

  2011cited by this paper
• Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells

  2011cited by this paper
• Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease.

  2011cited by this paper
• High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases

  2011cited by this paper
• In Situ Genetic Correction of the Sickle Cell Anemia Mutation in Human Induced Pluripotent Stem Cells Using Engineered Zinc Finger Nucleases

  2011cited by this paper
• In vivo genome editing restores hemostasis in a mouse model of hemophilia

  2011cited by this paper
• Genetic engineering of human ES and iPS cells using TALE nucleases

  2011cited by this paper
• Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting.

  2011cited by this paper
• A TALE nuclease architecture for efficient genome editing

  2011cited by this paper
• Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome.

  2010cited by this paper
• Engineering of human pluripotent stem cells by AAV-mediated gene targeting.

  2010cited by this paper

• A Novel Cell‐Penetrating Lipopeptide for DNA Binding, Self‐Assembly, and Delivery Into HeLa and Pluripotent Stem Cells

  2026cites this paper
• Modeling neurodegenerative diseases with brain organoids: from development to disease applications

  2025cites this paper
• Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing

  2024cites this paper
• Optimizing CRISPR/Cas9 precision: Mitigating off-target effects for safe integration with photodynamic and stem cell therapies in cancer treatment.

  2024cites this paper
• Genetically engineered human induced pluripotent stem cells for the production of brain-targeting extracellular vesicles

  2024cites this paper
• Microphysiological Blood‐Brain Barrier Systems for Disease Modeling and Drug Development

  2024cites this paper
• Enhancing genome editing in hPSCs through dual inhibition of DNA damage response and repair pathways

  2024cites this paper
• Gene editing with ‘pencil’ rather than ‘scissors’ in human pluripotent stem cells

  2023cites this paper
• CRISPR-Cas Technology as a Revolutionary Genome Editing tool: Mechanisms and Biomedical Applications

  2023cites this paper
• Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells

  2023cites this paper
• Gene Editing and Human iPSCs in Cardiovascular and Metabolic Diseases.

  2023cites this paper
• Physiological Electric Field: A Potential Construction Regulator of Human Brain Organoids

  2022cites this paper
• iPSC for modeling of metabolic and neurodegenerative disorders

  2022cites this paper
• Gene-Modified Stem Cells for Spinal Cord Injury: a Promising Better Alternative Therapy

  2022cites this paper
• Cell Cluster Sorting in Automated Differentiation of Patient-specific Induced Pluripotent Stem Cells Towards Blood Cells

  2022cites this paper
• Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

  2022cites this paper
• Tumorigenicity Assessment of Human Cancer Cell Lines Xenografted on Immunodeficient Mice as Positive Controls of Tumorigenicity Testing

  2022cites this paper
• Dendritic cells generated from induced pluripotent stem cells and by direct reprogramming of somatic cells

  2022cites this paper
• Direct visualization of the transition status during neural differentiation by dual-fluorescent reporter human pluripotent stem cells

  2022cites this paper
• A stress-reduced passaging technique improves the viability of human pluripotent cells

  2021influential citation
• High expression of uracil DNA glycosylase determines C to T substitution in human pluripotent stem cells

  2021cites this paper
• Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein

  2021cites this paper
• Human Pluripotent Stem Cells to Model Islet Defects in Diabetes

  2021cites this paper
• Comprehensive analysis of prime editing outcomes in human embryonic stem cells

  2021cites this paper
• CRISPR-Cas9-Mediated Gene Editing in Human Induced Pluripotent Stem Cells

  2021cites this paper
• Chromatin remodelling complexes in cerebral cortex development and neurodevelopmental disorders.

  2021cites this paper
• Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering

  2021cites this paper
• Multicellular modeling of ciliopathy by combining iPS cells and microfluidic airway-on-a-chip technology

  2021cites this paper
• Patient-Derived Induced Pluripotent Stem Cell Models for Phenotypic Screening in the Neuronal Ceroid Lipofuscinoses

  2021cites this paper
• Human artificial chromosomes for pluripotent stem cell-based tissue replacement therapy.

  2020cites this paper
• Hematopoietic Stem Cells

  2020cites this paper
• Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy

  2020influential citation
• Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.

  2020cites this paper
• Nintedanib Targets KIT D816V Neoplastic Cells Derived from Induced Pluripotent Stem cells of Systemic Mastocytosis

  2020cites this paper
• Brain organoids: an ensemble of bioassays to investigate human neurodevelopment and disease

  2020cites this paper
• Science Runs and the Debate Brakes: Somatic Gene-Editing as a New Tool for Gender-Specific Medicine in Alzheimer’s Disease

  2020cites this paper
• Induced Pluripotent Stem Cell Meets Severe Combined Immunodeficiency

  2020cites this paper
• Targeted delivery for neurodegenerative disorders using gene therapy vectors: Gen next therapeutic goals.

  2020cites this paper
• CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy

  2020cites this paper
• Pluripotent stem cell-based gene therapy approach: human de novo synthesized chromosomes

  2020cites this paper
• Modelling multiple sclerosis using induced pluripotent stem cells.

  2020cites this paper
• Human sensory neurons derived from pluripotent stem cells for disease modelling and personalized medicine

  2020cites this paper
• Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.

  2020cites this paper
• iPSC for modeling neurodegenerative disorders

  2020cites this paper
• 3D gastrointestinal models and organoids to study metabolism in human colon cancer.

  2020cites this paper
• Genetik menschlicher Erkrankungen

  2020cites this paper
• Gene editing and gender-specific medicine: a challenge for dementia research

  2020cites this paper
• 27 Biodemography

  2019cites this paper
• Special issue on stem cell and tissue engineering in development, disease, and repair

  2019cites this paper
• Development of CRISPR-Cas systems for genome editing and beyond

  2019cites this paper
• Induced pluripotent stem cells (iPSCs) based approaches for hematopoietic cancer therapy

  2019cites this paper
• Gene Editing in Human Pluripotent Stem Cells: Recent Advances for Clinical Therapies.

  2019cites this paper
• Scientific Basis for Stem Cell Therapy

  2019cites this paper
• The role of CXC receptors signaling in early stages of mouse embryonic stem cell differentiation.

  2019cites this paper
• S0033583519000052jrv 1..31

  2019cites this paper
• Use of big data in drug development for precision medicine: an update

  2019cites this paper
• Developing an induced pluripotent stem cell model of pulmonary arterial hypertension to understand the contribution of BMPR2 mutations to disease-associated phenotypes in smooth muscle cells

  2019cites this paper
• Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease

  2019cites this paper
• Genetic correction of induced pluripotent stem cells mediated by transcription activator-like effector nucleases targeting ALPL recovers enzyme activity and calcification in vitro.

  2019cites this paper
• Systems-Wide Approaches in Induced Pluripotent Stem Cell Models.

  2019cites this paper
• Induced Pluripotent Stem Cells in Tissue Engineering and Regenerative Medicine

  2019cites this paper
• Programmable Molecular Scissors: Applications of a New Tool for Genome Editing in Biotech

  2018cites this paper
• Precision Medicine: Changing the way we think about healthcare

  2018cites this paper
• Disease Modeling and Drug Development with DM1 Patient-Derived iPS Cells

  2018cites this paper
• Cholesterol metabolism and statin effects on an FH class II LDL-receptor mutation.

  2018influential citation
• Comparison of different methods to overexpress large genes

  2018cites this paper
• Gene and Cell Therapy for Muscular Dystrophies: Are We Getting There?

  2018cites this paper
• Precision gene editing technology and applications in nephrology

  2018cites this paper
• Concepts toward directing human astroplasticity to promote neuroregeneration

  2018cites this paper
• Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications

  2018cites this paper
• Site-specific randomization of the endogenous genome by a regulatable CRISPR-Cas9 piggyBac system in human cells

  2018cites this paper
• Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications

  2018cites this paper
• Transfer of Synthetic Human Chromosome into Human Induced Pluripotent Stem Cells for Biomedical Applications

  2018cites this paper
• Tailoring non-viral delivery vehicles for transporting genome-editing tools

  2017cites this paper
• Direct conversion from skin fibroblasts to functional dopaminergic neurons for biomedical application

  2017cites this paper
• Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.

  2017cites this paper
• A novel system for correcting large-scale chromosomal aberrations: ring chromosome correction via reprogramming into induced pluripotent stem cell (iPSC)

  2017cites this paper
• CRISPR/Cas9-Mediated Mutagenesis of Human Pluripotent Stem Cells in Defined Xeno-Free E8 Medium.

  2017cites this paper
• Generation of neural cells using iPSCs from sleep bruxism patients with 5-HT2A polymorphism.

  2017cites this paper
• Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy

  2017cites this paper
• Application of CRISPR-Cas9 in eye disease.

  2017cites this paper
• When Long Noncoding RNAs Meet Genome Editing in Pluripotent Stem Cells

  2017cites this paper
• Master regulators in development: Views from the Drosophila retinal determination and mammalian pluripotency gene networks.

  2017cites this paper
• Applied Cultural and Social Studies are Needed for a Sustainable Reduction of Genetic Disease Incidence

  2017cites this paper
• Cell therapy for basement membrane-linked diseases.

  2017cites this paper
• Ten years since the discovery of iPS cells: The current state of their clinical application

  2017cites this paper
• Hemophilia Gene Therapy; Clinical and Molecular Aspects

  2017cites this paper
• Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases☆

  2017cites this paper
• Chapter 76 – Nephron Progenitors

  2017cites this paper
• Synthetic gene circuits and cellular decision-making in human pluripotent stem cells

  2017cites this paper
• Direct Production of Human Cardiac Tissues by Pluripotent Stem Cell Encapsulation in Gelatin Methacryloyl.

  2017cites this paper
• muscular dystrophies Gene Editing With CRISPR / Cas 9 RNA-Directed Nuclease

  2017cites this paper
• Ten years since the discovery of iPS cells: The current state of their clinical application.

  2017cites this paper
• Development of an Intrinsic Skin Sensor for Blood Glucose Level with CRISPR-mediated Genome Editing in Epidermal Stem Cells

  2017cites this paper
• Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease

  2017cites this paper
• Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.

  2016cites this paper
• Recycled alterity: Familiar dehumanisation in the contemporary fiction of genetic posthumanism

  2016cites this paper
• Diez años desde el descubrimiento de las células IPS: estado actual de su aplicación clínica

  2016cites this paper
• Creating a 3D Stem Cell Microenvironment to Produce Human Developing Cardiac Tissues for Scale-Up and Disease Modeling

  2016cites this paper
• Genome editing: An alternative to retroviral vectors for Wiskott-Aldrich Syndrome (WAS) Gene Therapy?

  2016cites this paper